Antitubercular lanostane triterpenoids isolated from mycelial cultures of the basidiomycete Ganoderma australe were structurally modified by semisynthesis. One of the synthetic compounds, named GA003 (9), showed more potent activity against Mycobacterium tuberculosis H37Ra than the lead natural lanostane (1). GA003 was also significantly active against the virulent strain (H37Rv) as well as extensively drug-resistant tuberculosis strains.

01 Jul 2013·Journal of Basic MicrobiologyQ4 · BIOLOGY

Cadophora malorumCs-8-1 as a new fungal strain producing gibberellins isolated fromCalystegia soldanella

Q4 · BIOLOGY

Article

Author: You, Young-Hyun ; Lee, In-Jung ; Woo, Ju-Ri ; Kim, Jong-Guk ; Kang, Sang-Mo ; Choo, Yeon-Sik ; Yoon, Hyeokjun ; Shin, Jae-Ho

Fourteen endophytic fungi with different colony morphologies were isolated from the roots of Calystegia soldanella. Endophytic fungi isolated from C. soldanella were identified by internal transcribed spacer (ITS) region. To verify plant growth promotion (PGP), culture filtrates of isolated endophytic fungi were treated in Waito-c rice (WR) and C. soldanella seedlings. Culture filtrates of Cs-8-1 fungal strain had advanced PGP activity. The presence of physiologically bioactive gibberellins (GA) GA(1) (1.213 ng ml(-1)), GA(3) (1.292 ng ml(-1)), GA(4) (3.6 ng ml(-1)), GA(7) (1.328 ng ml(-1)), other inactive GA(9) (0.796 ng ml(-1)) and GA(12) (0.417 ng ml(-1)), GA(20) (0.302 ng ml(-1)), GA(24) (1.351 ng ml(-1)), GA(34) (0.076 ng ml(-1)), and GA(53) (0.051 ng ml(-1)) in culture filtrates of Cs-8-1 fungal strain was detected. The Cs-8-1 fungal strain was confirmed as a producer of GAs. Molecular analysis of sequences showed high similarity of 99% to Cadophora malorum. Consequentially, the Cs-8-1 fungal strain was identified as a new C. malorum producing GAs.

01 Jun 2013·Food ChemistryQ1 · AGRICULTURAL & FORESTRY SCIENCE

Degradation pattern of gibberellic acid during the whole process of tea production

Q1 · AGRICULTURAL & FORESTRY SCIENCE

Article

Author: Xin Liu ; Peng Yin ; Hongping Chen ; Dan Yang

The residues of gibberellic acid (GA(3)) in tea shoots, made tea, and tea infusion were determined by ultra-performance liquid chromatography tandem mass (UPLC-MS/MS) to study its degradation pattern during tea planting, processing, and brewing. The dissipation rate of GA(3) was described using first-order kinetics. Its half-life ranged from 1.67 to 2.01 days in tea shoots. Degradation and concentration during green tea processing had equally important functions on GA(3) residues in product intermediates and made tea. Except for water content, little GA(3) residue difference was found in tea shoots and made tea. GA(3) dissipated rapidly in the baking stage during processing. The transfer coefficient of GA(3) residues from made tea to infusion was from 26.23% to 54.55%. GA(3) extraction efficiency varied with different infusion times and concentrations of GA(3) in made tea. This research revealed that GA(3) may be safe when applied in tea gardens at suitable doses and picking intervals.

100 Deals associated with GA-003

R&D Status

10 top R&D records.

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Hematologic Diseases	Preclinical	JP	Nissan Chemical Corp.	-
Hematologic Diseases	Preclinical	JP	Niigata University	-
Hematologic Diseases	Preclinical	JP	University of Tokyo	-

Clinical Result

Indication

Phase

Evaluation

View All Results

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Deal

Boost your decision using our deal data.

view full example data

Core Patent

Boost your research with our Core Patent data.

view full example data

Clinical Trial

Identify the latest clinical trials across global registries.

view full example data

Approval

Accelerate your research with the latest regulatory approval information.

view full example data

Regulation

Understand key drug designations in just a few clicks with Synapse.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis


No Data

GA-003

Overview

Basic Info

Related

R&D Status

Clinical Result

Translational Medicine

Deal

Core Patent

Clinical Trial

Approval

Regulation